Auxilium Biotechnologies Inc. — Form D/A
Auxilium Biotechnologies Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2025-12-11. The offering totals $10.0M, of which $3.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-12-11
- Form: D/A
- Accession: 0001800618-25-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $3.9M
- Remaining: $6.1M
- Investors: 16
- Date of first sale: 2025-09-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-561785
Issuer
- Name: Auxilium Biotechnologies Inc.
- CIK: 0001800618
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 4923 Bradshaw Ct., SAN DIEGO, CA, 92130
- Phone: (858) 699-9443
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Craig Andrews | Director | San Diego, CA |
| Robert Engler | Director | San Diego, CA |
| Yacov Koffler | Director | San Diego, CA |
| Mark Tuszynski | Director | San Diego, CA |
| Yacov Koffler | Executive Officer | San Diego, CA |
| Donald Cohn | Director | La Jolla, CA |
Other filings by this issuer (2)
More